A Dose-Range Finding Study for ALX-0061 Combination Therapy in Subjects With Rheumatoid Arthritis

Clinical trial NCT02309359 · COMPLETED

Trial details

NCT number: NCT02309359
Sponsor: Ablynx, a Sanofi company
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Rheumatoid Arthritis

Start date: 2015-01-01
Primary completion: 2016-08-01
Enrollment: 345

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.